human
papillomaviru
hpv
common
sexual
transmit
infect
world
main
caus
cervic
cancer
global
cancer
worldwid
case
per
year
men
case
per
year
women
attribut
viral
type
hpv
identifi
whose
classif
base
associ
cervic
cancer
precursor
lesion
hpv
type
classifi
highrisk
lowrisk
type
consist
gener
squamou
cell
carcinoma
uterin
papillomaviru
doublestrand
circular
dna
genom
encod
roughli
eight
openread
frame
orf
respons
viral
replic
mainten
cell
transform
gene
product
classifi
six
nonstructur
regulatori
protein
two
structur
capsid
protein
nowaday
viruslik
particl
vlp
base
protein
consid
best
candid
vaccin
develop
hpv
infect
two
commerci
hpv
vaccin
prophylact
gardasil
protect
hpv
genotyp
cervarix
protect
hpv
genotyp
prevent
cervic
cancer
almost
hpv
vlp
vaccin
confer
protect
limit
although
variabl
level
crossprotect
also
observ
phylogenet
relat
hpv
major
impedi
econom
barrier
especi
gap
financ
obstruct
optim
deliveri
vaccin
develop
countri
might
approach
via
local
produc
gener
vaccin
storag
transport
socal
cold
chain
anoth
hindranc
mitig
lyophil
protect
also
note
mani
recombin
vaccin
reli
multipl
immun
howev
promis
result
could
obtain
singl
dose
certainli
recent
possibl
approach
broader
crosstyp
protect
immun
lower
cost
consid
vaccin
compar
vlp
inde
current
hpv
vaccin
improv
typespecif
protect
recent
studi
show
region
nterminu
neutral
antibodi
gener
variou
type
hpv
overcom
intrins
low
immunogen
recombin
protein
potenc
could
increas
variou
formul
multival
epitop
peptid
vaccin
fusion
immunogen
multiepitop
dnabas
major
field
scienc
bioinformat
brought
togeth
concept
silico
analys
biolog
queri
mathemat
immunoinformat
tool
could
help
research
screen
multipl
hpv
genom
predict
high
immunogen
epitop
provid
b
cell
respons
hpv
studi
combin
silicoin
vivo
approach
use
evalu
protein
highrisk
hpv
type
design
pan
genotyp
construct
develop
dnabas
vaccin
select
conserv
epitop
hpv
subtyp
protein
sequenc
align
use
muscl
algorithm
base
degre
conserv
five
region
protein
four
region
protein
select
immunebioinformat
analysi
b
tcell
epitop
predict
among
region
protein
region
protein
highest
score
conserv
highrisk
hpv
type
addit
base
sequenc
variabl
conserv
region
protein
two
main
type
hpv
select
refer
calcul
conserv
iedb
epitop
conserv
analysi
tool
tabl
bcell
epitop
recogn
bcell
receptor
antibodi
nativ
structur
continu
bcell
epitop
predict
similar
tcell
epitop
predict
mainli
base
amino
acid
properti
hydrophob
expos
surfac
area
charg
secondari
structur
first
step
conserv
region
sequenc
analyz
server
predict
potenti
bcell
epitop
tabl
protein
nfgvppppttslvdtype
epitop
best
b
cell
epitop
identif
score
protein
epitop
show
highest
epitop
identif
score
protein
sequenc
sinc
linear
form
tcell
epitop
bound
mhc
interfac
tcell
ligand
accur
model
studi
use
three
differ
algorithm
publish
motif
ann
quantit
matrix
mhci
two
algorithm
mhcii
ann
quantit
matrix
first
step
conserv
region
analyz
find
immunodomin
peptid
use
netmhcpan
syfpeithi
propr
protein
peptid
highest
bind
affin
score
determin
highpotenti
ctl
epitop
candid
tabl
analysi
show
ylppvpvskvtype
ylpppsvarvtyp
dqfplgrkflltype
dqyplgrkflvtyp
krasatqlyktyp
krasvtdlyktyp
dpdfldivalhrtyp
dsdfmdiirlhrtyp
epitop
highest
bind
affin
among
protein
sequenc
gener
result
three
differ
algorithm
confirm
conserv
allergen
analys
done
select
epitop
sequenc
epitop
well
conserv
among
highrisk
hpv
type
none
allergen
tabl
addit
crossreact
peptid
human
proteom
studi
use
netmhciipan
propr
server
mhcii
epitop
identif
analysi
tabl
sinc
suitabl
tcell
epitop
predict
bind
differ
hla
allel
epitop
maximum
number
bind
hladr
allel
select
highpotenti
helper
tcell
epitop
candid
among
predict
epitop
eatvylppvpvskvvtyp
tqrlvwacvgvevgrgqtyp
tqrlvwacagveigrgqtyp
dtyrfvtsqaiacqktyp
dtyrfvqsvaitcqktyp
dpsivtliedssvvtsgaptyp
pdfldivalhrpaltsrtyp
sdfmdiirlhrpaltsrtyp
highest
score
bind
affin
also
sequenc
epitop
well
conserv
among
highrisk
hpv
type
none
allergen
tabl
also
crossreact
peptid
human
proteom
gener
antigen
peptid
transport
across
membran
endoplasm
reticulum
assembl
mhc
class
molecul
essenti
step
antigen
present
cytotox
lymphocyt
thu
investig
proteasom
cleavag
tap
transport
affin
predict
bind
essenti
present
pathway
server
use
predict
tap
transport
effici
proteasom
cleavag
score
tabl
epitop
ylppvpvskvtype
ylpppsvarvtyp
dqfplgrkflltype
dqyplgrkflvtyp
krasatqlyktyp
krasvtdlyktyp
dpdfldivalhrtyp
dsdfmdiirlhrtyp
epitop
highest
epitop
identif
score
hla
distribut
vari
among
divers
geograph
region
around
world
thu
design
effect
vaccin
popul
coverag
must
taken
consider
cover
maximum
possibl
popul
studi
popul
coverag
estim
separ
put
epitop
specifi
geograph
region
world
tabl
ctl
epitop
highest
popul
coverag
world
popul
calcul
helper
tcell
epitop
highest
popul
coverag
calcul
overal
result
indic
highpotenti
helper
tcell
epitop
ctl
epitop
specif
bind
preval
hla
molecul
target
popul
vaccin
employ
peptid
promis
candid
differ
type
biolog
applic
vaccin
design
recent
year
varieti
approach
reveal
proteinpeptid
dock
predict
structur
proteinpeptid
complex
start
protein
structur
peptid
sequenc
includ
variabl
degre
inform
peptid
bind
site
andor
conform
studi
two
differ
algorithm
templatebas
global
dock
use
calcul
dock
score
mhc
allel
peptid
first
structur
data
mhci
mhcii
download
rcsb
pdb
server
http
wwwrcsborg
potenti
epitop
mhc
pdb
file
submit
server
separ
top
model
highest
cluster
densiti
number
element
divid
averag
cluster
rmsd
obtain
cabsdock
server
interact
similar
score
similar
amino
acid
target
complex
align
contact
residu
templat
structur
templat
amino
acid
obtain
galexypepdock
server
select
peptid
mhc
tabl
result
mhc
allel
might
vari
averag
score
similar
score
cluster
densiti
confirm
ctl
epitop
highest
averag
dock
score
server
helper
tcell
epitop
highest
averag
dock
score
server
figur
repres
sampl
success
dock
model
peptid
mhc
protein
success
dock
mean
epitop
bind
mhc
molecul
interact
r
group
side
chain
pocket
locat
floor
mhc
molecul
moreov
tabl
show
mhc
allel
use
peptideprotein
dock
perform
analysi
toprank
epitop
select
accord
paramet
bind
affin
peptid
mhc
mhci
ii
allel
epitop
identif
score
bcell
proteasom
cleavag
tap
transport
score
conserv
degre
hpv
subtyp
popul
coverag
score
peptideprotein
dock
base
toprank
epitop
two
differ
construct
design
fig
structur
type
type
type
type
type
type
epitop
select
structur
type
type
type
type
type
type
epitop
present
tabl
structur
two
repeat
epitop
place
togeth
aay
proteolyt
linker
alanin
alanin
tyrosin
physicochem
properti
construct
molecular
weight
instabl
index
antigen
solubl
estim
half
time
summar
tabl
design
hpv
gene
correctli
clone
eukaryot
vector
presenc
gene
confirm
digest
clear
band
bp
bp
agaros
gel
respect
data
shown
recombin
endotoxinfre
plasmid
ie
concentr
rang
mgml
vitro
dna
deliveri
eukaryot
cell
line
perform
turbofect
transfect
reagent
level
dna
express
evalu
use
fluoresc
microscopi
flow
cytometri
h
posttransfect
data
indic
effect
penetr
cell
vitro
cellular
uptak
gene
cell
respect
deliveri
posit
control
detect
approxim
cell
fig
moreov
spread
green
region
observ
dna
deliveri
use
turbofect
carrier
fluoresc
microscopi
cell
hand
western
blot
analysi
indic
success
express
protein
fuse
gfp
ie
use
antigfp
antibodi
data
indic
clear
band
kda
gfp
respect
use
dab
substrat
fig
evalu
prophylact
effect
design
dna
construct
tumor
growth
surviv
percentag
assess
group
day
challeng
tumor
cell
shown
fig
test
group
immun
dna
construct
demonstr
significantli
lower
tumor
growth
control
group
pb
empti
vector
p
data
show
progress
tumor
growth
control
group
approxim
day
surviv
rate
tumorfre
mice
percentag
interest
group
vaccin
dna
dna
dna
construct
similarli
reduc
tumor
growth
p
shown
fig
group
vaccin
mixtur
dna
construct
show
higher
surviv
rate
dna
construct
alon
level
total
immunoglobulin
g
igg
mice
immun
mixtur
dna
construct
significantli
higher
group
p
fig
c
moreov
data
show
level
similar
group
vaccin
dna
construct
p
fig
signific
differ
secret
isotyp
group
receiv
dna
construct
alon
p
fig
signific
anti
antibodi
respons
could
detect
sera
control
group
thu
seroreact
complet
antigenspecif
respons
mice
result
cytokin
assay
group
show
level
specif
secret
group
immun
dna
construct
significantli
higher
control
group
p
fig
contrast
signific
differ
mice
vaccin
dna
construct
alon
secret
cytokin
p
among
test
group
group
immun
dna
construct
show
signific
ifngamma
respons
compar
group
p
fig
furthermor
data
indic
ratio
higher
test
group
compar
control
group
therefor
could
trigger
immun
respons
secret
granzym
b
test
group
significantli
higher
control
group
p
fig
group
immun
dna
construct
produc
significantli
higher
concentr
granzym
b
group
p
level
granzym
b
group
receiv
dna
construct
similar
group
receiv
dna
construct
p
recent
year
develop
bioinformat
tool
appli
vaccin
research
could
potenti
save
time
resourc
inde
immunoinformat
tool
help
identifi
antigen
domain
design
multiepitop
vaccin
sequencebas
technolog
advanc
enough
inform
genom
proteom
differ
thu
use
variou
bioinformat
tool
design
peptid
vaccin
base
neutral
epitop
exampl
silico
design
epitopebas
vaccin
human
immunodefici
dengu
saint
loui
enceph
alreadi
report
around
highrisk
hpv
recogn
current
vaccin
protect
human
type
import
limit
current
vaccin
narrow
coverag
access
fulli
sequenc
proteom
highrisk
hpv
strain
provid
prospect
silico
screen
reliabl
peptidebas
therapeut
vaccin
candid
among
billion
possibl
immunogen
peptid
silico
approach
intend
reflect
possibl
overcom
abovement
difficulti
hpv
multityp
vaccin
gupta
cowork
design
prophylact
multiepitop
dna
vaccin
use
consensu
epitop
sequenc
hpv
capsid
protein
also
evalu
engin
cpg
motif
bioinformat
tool
could
increas
immunogen
dna
hosseini
et
al
appli
silico
analysi
protein
hpv
type
identifi
univers
peptid
vaccin
order
protect
mention
singh
et
al
analyz
protein
highrisk
hpv
type
identifi
tcell
epitop
suggest
pool
peptid
amino
acid
provid
protect
highrisk
hpv
panahi
colleagu
use
twostep
method
consist
molecular
dock
sequencebas
approach
determin
immunogen
epitop
induct
immun
system
oncoprotein
hpv
wang
cowork
suggest
region
put
bcell
epitop
sabah
et
al
use
silico
immunoinformat
tool
report
conserv
mer
epitop
estvheiel
among
bristo
et
al
design
mhcimhcii
hybrid
ra
oncopeptid
could
elicit
tcell
repons
anim
research
design
framework
comprehens
analysi
conserv
region
highrisk
hpv
type
contain
mhci
mhcii
epitop
framework
begin
conserv
analysi
highrisk
hpv
strain
follow
bcell
epitop
map
tcell
epitop
map
allergen
assess
tap
transport
proteasom
cleavag
popul
coverag
global
templatebas
dock
data
collect
analysi
design
dna
construct
experiment
analysi
final
dna
construct
clone
mammalian
express
vector
green
fluoresc
tag
pegfp
vector
express
evalu
eukaryot
cell
use
flow
cytometri
fluoresc
microscopi
western
blot
moreov
antibodi
tcell
immun
respons
induc
dna
construct
assess
mous
tumor
model
first
sequenc
obtain
highrisk
hpv
type
align
use
muscl
algorithm
conserv
analysi
show
five
region
protein
four
region
protein
conserv
among
subtyp
could
analyz
immunoinformat
input
bcell
epitop
predict
highest
epitop
predict
score
unfortun
reliabl
method
predict
bcell
epitop
reveal
sensit
specif
exist
method
low
specif
sensit
method
respect
case
tcell
epitop
predict
silico
analysi
significantli
improv
thu
result
reliabl
studi
mhci
epitop
epitop
highest
bind
affin
score
addit
abovement
epitop
highest
tcell
epitop
predict
score
obtain
proteasom
cleavag
tap
transport
analysi
high
degre
conserv
observ
subtyp
epitop
tabl
especi
sequenc
ident
hpv
type
high
similar
rate
hpv
addit
sequenc
higher
degre
conserv
hpv
mhcii
predict
epitop
highest
bind
affin
score
among
greatest
degre
conserv
high
similar
highrisk
hpv
type
one
remark
point
epitop
overlap
littl
differ
among
bcell
mhcii
select
epitop
due
limit
mhcpeptid
bind
predict
gap
peptid
predict
bind
mhc
experiment
flexibl
molecular
dock
employ
address
problem
rais
accuraci
mhcpeptid
predict
current
studi
templatebas
dock
also
global
dock
perform
select
peptid
determin
peptid
would
get
groov
mhc
highest
model
score
mhci
epitop
sequenc
highest
interact
similar
cluster
densiti
score
mhcii
epitop
sequenc
highest
dock
score
studi
mhcipeptid
dock
score
confirm
mhcipeptid
bind
affin
score
epitop
highest
score
method
mhcii
molecular
dock
result
slightli
differ
one
reason
signific
conform
chang
process
due
longer
epitop
length
gener
rule
longer
length
queri
peptid
torsion
conform
herein
due
longer
peptid
sequenc
dock
result
mhcii
less
accur
mhci
exampl
averag
similar
score
mhci
variabl
mhcii
complet
analysi
accord
abovement
paramet
two
separ
construct
design
addit
accumul
popul
coverag
helper
tcell
ctl
epitop
design
construct
estim
construct
combin
epitop
candid
helper
tcell
ctl
singl
univers
vaccin
could
involv
world
popul
rate
respect
fig
previou
studi
ylppvpvskv
krasvtdlyk
report
potenti
immunogen
epitop
abil
vitro
express
design
dna
construct
determin
cell
use
flow
cytometri
western
blot
analysi
transfect
effici
dna
construct
respect
indic
high
potenc
deliveri
eukaryot
cell
known
use
polytop
dna
vaccin
contain
multipl
tcell
bcell
epitop
attract
strategi
develop
therapeut
prophylact
vaccin
hpv
infect
vitro
assay
immunolog
experi
perform
mice
determin
effici
design
dna
construct
without
use
adjuv
deliveri
system
vaccin
develop
similarli
studi
use
pcdna
vector
harbor
gene
interest
immun
without
data
indic
group
immun
dna
construct
increas
antibodi
tcell
respons
compar
control
group
furthermor
specif
immun
mice
receiv
mixtur
dna
construct
result
higher
secret
total
igg
cytokin
well
granzym
b
group
higher
level
well
ifngamma
cytokin
group
drive
tcell
respons
toward
immun
studi
show
immunoglobulin
relat
respons
respons
associ
induct
regard
observ
protect
studi
regimen
dna
construct
could
confer
protect
tumorchalleng
mice
surviv
rate
depend
stimul
celldomin
respons
well
granzym
b
secret
indic
ctl
activ
compar
dna
construct
alon
surviv
rate
data
show
high
potenc
combin
dna
construct
versu
dna
construct
alon
prophylact
hpv
vaccin
taken
togeth
immunoinformat
approach
emerg
critic
field
acceler
immunolog
research
yet
immunoinformat
techniqu
appli
tcell
advanc
deal
moreov
recent
due
limit
option
choos
adjuv
clinic
trial
bioinformat
analys
develop
predict
best
adjuv
way
silico
studi
help
research
save
time
resourc
also
guid
experiment
work
higher
probabl
find
desir
solut
fewer
trial
error
repeat
assay
access
hpv
genom
sequenc
function
character
gene
involv
virul
significantli
improv
understand
molecular
foundat
pathogenesi
hpv
offer
wealth
data
use
design
new
plan
vaccin
design
nowaday
power
immun
system
simul
develop
use
bioinformat
tool
predict
artifici
immun
provid
vaccin
approach
could
predict
best
adjuv
use
human
vaccin
studi
multiscal
comput
infrastructur
approach
stimul
dynam
immun
respons
induc
sever
vaccin
formul
predict
optim
combin
term
adjuv
type
dosag
time
netlogo
agentbas
model
immun
system
run
differ
simul
differ
paramet
set
also
interact
differ
model
strategi
includ
investig
pathogen
growth
life
cycl
model
environ
simul
complex
therefor
use
method
increas
effici
reduc
cost
vaccin
studi
studi
first
time
comprehens
integr
method
use
sequencebas
tool
combin
flexibl
peptideprotein
dock
use
design
highli
immunogen
protect
vaccin
candid
abl
boost
humor
cellular
immun
respons
highrisk
hpv
type
addit
vivo
analysi
demonstr
high
potenc
design
construct
combin
dnabas
vaccin
without
use
adjuv
deliveri
system
howev
improv
effici
dnabas
vaccin
use
deliveri
system
also
compar
efficaci
design
peptidebas
vaccin
along
adjuv
near
futur
refer
protein
sequenc
highrisk
hpv
strain
gi
gi
gi
gi
gi
gi
gi
gi
gi
gi
gi
gi
gi
gi
gi
gi
gi
gi
gi
gi
gi
gi
gi
gi
gi
gi
extract
pave
databas
http
paveniaidnihgov
use
input
futur
bioinformat
analysi
determin
conserv
epitop
differ
subtyp
sequenc
dataset
first
align
use
snapgen
softwar
gsl
biotech
avail
snapgenecom
protein
align
analysi
use
muscl
algorithm
conserv
epitop
protein
select
immunebioinformat
analysi
b
tcell
epitop
predict
also
calcul
degre
variabl
conserv
epitop
iedb
epitop
conserv
tool
http
toolsimmuneepitopeorgtoolsconserv
use
success
vaccin
must
elicit
strong
tcell
bcell
immun
respons
provid
protect
diseas
target
therefor
essenti
show
construct
immunogen
abl
induc
protect
cellular
humor
immun
sinc
antibodi
induc
linear
bcell
epitop
would
difficult
synthes
long
peptid
nativ
protein
conform
resembl
induct
protect
antibodi
howev
optim
peptidebas
vaccin
present
desir
secondari
structur
peptid
order
induc
specif
humor
bcell
epitop
predict
conserv
region
protein
server
http
employ
studi
epitop
threshold
valu
set
specif
sensit
method
respect
mhci
epitop
predict
initi
step
appli
bioinformat
vaccin
research
assess
potenti
immunoprotect
epitop
tcell
epitop
present
mhc
molecul
typic
linear
form
contain
amino
acid
fact
facilit
accur
model
interact
ligand
thu
select
step
present
antigen
peptid
tcell
receptor
tcr
bind
mhc
studi
tri
use
three
differ
algorithm
includ
artifici
neural
network
netmhcpan
http
wwwcbsdtudkservicesnetmhcpan
quantit
matrix
propr
http
publish
motif
syfpeithi
http
wwwsyfpeithid
predict
highpotenti
tcell
epitop
netmhcpan
percentil
rank
set
strong
binder
weak
binder
propr
threshold
set
mhcii
epitop
predict
mhc
class
ii
netmhciipan
http
wwwcbsdtudkservicesnetmhciipan
http
crddosddnetraghavapropr
employ
predict
potenti
interact
helper
tcell
epitop
peptid
mhcii
case
threshold
strong
weak
binder
set
respect
investig
tap
transport
proteasom
cleavag
well
affin
predict
bind
essenti
mhci
present
pathway
studi
use
netctl
server
combin
tap
transportproteasom
cleavag
tool
http
wwwcbsdtudkservicesnetctl
access
predict
antigen
process
mhc
class
antigen
present
pathway
method
paramet
weight
ctermin
cleavag
tap
transport
effici
epitop
identif
set
default
respect
sinc
respons
tcell
epitop
restrict
mhc
select
epitop
multipl
hlabind
increas
popul
coverag
defin
geograph
region
peptidebas
vaccin
might
employ
coverag
rate
popul
epitop
comput
valid
use
iedb
popul
coverag
populationiedbinput
studi
individu
epitop
bind
hla
allel
analyz
differ
geograph
area
also
select
sinc
protein
import
induc
allergen
reaction
predict
potenti
allergen
import
item
safeti
assess
especi
field
genet
modifi
food
therapeut
biopharmaceut
food
agricultur
organ
fao
world
health
organ
protocol
includ
three
term
evalu
allergen
protein
defin
follow
term
sensit
refer
correctli
predict
allergen
wherea
specif
refer
correctli
predict
nonallergen
also
accuraci
refer
proport
correctli
predict
allergen
epitop
analyz
http
use
allergen
onlin
wordmatch
afdsmotif
algorithm
base
amino
acid
composit
specif
method
adf
assess
crossreact
peptid
human
proteom
toprank
epitop
analyz
peptid
match
program
http
researchbioinformaticsudeledupeptidematchindexjsp
base
toprank
epitop
two
differ
construct
design
physicochem
properti
toprank
epitop
solubl
molecular
weight
estim
halftim
instabl
index
antigen
determin
protparam
http
webexpasyorgprotparam
http
wwwddgpharmfacnetvaxijenvaxijenvaxijenhtml
proteinsol
http
proteinsolmanchesteracuk
bioinformat
analysi
select
peptid
assembl
two
separ
construct
fig
construct
synthes
biomatik
compani
vitro
experi
vector
digest
xhoihindiii
gene
subclon
xhoihindiii
site
vector
individu
ie
recombin
vector
transform
escherichia
coli
e
coli
strain
extract
plasmid
singl
coloni
use
minikit
qiagen
presenc
insert
fragment
confirm
digest
restrict
enzym
sequenc
vivo
immunolog
assess
vector
digest
bamhihindiii
gene
subclon
bamhihindiii
site
vector
contain
cytomegaloviru
earli
promot
enhanc
sequenc
individu
ie
inde
use
pcdna
vector
harbor
cpg
motif
vivo
studi
final
point
recombin
dna
vector
harbor
gene
purifi
endotoxinfre
plasmid
extra
ef
kit
macherey
nagel
germani
concentr
puriti
recombin
dna
construct
determin
nanodrop
human
embryon
kidney
cell
cultur
rpmi
supplement
fetal
bovin
serum
fb
atmospher
passag
cell
seed
plate
optim
cell
confluenc
effect
transfect
consid
gener
turbofectplasmid
dna
complex
turbofect
thermo
scientif
plasmid
posit
control
mix
incub
min
room
temperatur
complex
ad
well
serumfre
media
addit
nontransfect
cell
use
neg
control
six
hour
media
replac
complet
rpmi
medium
final
cell
harvest
wash
resuspend
pb
buffer
analyz
express
dna
construct
use
flow
cytometri
fluoresc
microscopi
western
blot
hr
cell
scrape
plate
wash
wash
step
cell
lyse
wholecel
lysi
buffer
glycerol
nm
dtt
mm
natrium
fluorid
triton
edta
pb
ph
extract
protein
sampl
gfp
separ
sdspage
wv
polyacrylamid
gel
transfer
nitrocellulos
membran
millipor
membran
equilibr
tbst
trisbuff
salin
solut
contain
bsa
bovin
albumin
serum
overnight
antigfp
polyclon
antibodi
vv
acri
antibodi
gmbh
use
recogn
express
protein
standard
procedur
immunoreact
protein
band
visual
detect
peroxidas
activ
use
substrat
name
dab
sigma
immunolog
assay
ie
secret
antibodi
cytokin
granzym
b
two
peptid
construct
peptid
fig
synthes
biomatik
co
puriti
five
group
six
femal
mice
obtain
breed
stock
maintain
pasteur
institut
iran
mhc
haplotyp
immun
day
ie
three
time
interv
plasmid
dna
combin
right
footpad
shown
tabl
control
group
receiv
pb
respect
mice
maintain
specif
pathogenfre
moreov
anim
experiment
procedur
approv
anim
care
use
committe
pasteur
institut
iran
carri
accord
anim
experiment
regul
pasteur
institut
iran
nation
guidelin
scientif
purpos
code
vivo
protect
assay
vaccin
mice
subcutan
challeng
right
flank
tumor
cell
cell
two
week
last
inject
tumor
cell
contain
whole
genom
presenc
gene
confirm
previou
tumor
growth
percentag
tumorfre
mice
monitor
twice
week
palpat
day
postchalleng
time
tumor
volum
calcul
formula
v
smallest
diamet
b
biggest
diamet
two
week
last
inject
serum
sampl
collect
group
level
goat
antimous
immunoglobulin
total
igg
antibodi
dilut
bsapbstween
sigma
secret
bcell
measur
pool
sera
group
indirect
elisa
coat
antigen
mixtur
synthet
peptid
moreov
mice
sera
dilut
three
mice
group
sacrif
spleen
remov
red
blood
celldeplet
pool
splenocyt
cellsml
cultur
plate
h
presenc
peptid
rpmi
neg
control
concanavalin
cona
posit
control
complet
rpmi
cultur
medium
supernat
harvest
assess
secret
tcell
use
sandwichbas
elisa
method
r
system
accord
manufactur
instruct
data
repres
mean
sd
measur
granzym
b
grb
elisa
target
cell
seed
plate
cellswel
incub
mixtur
peptid
h
prepar
splenocyt
effector
cell
e
section
count
ad
target
cell
e
ratio
complet
rpmi
cultur
medium
h
incub
final
supernat
harvest
measur
concentr
grb
elisa
ebiosci
kit
accord
manufactur
statist
analys
perform
prism
graphpad
san
diego
california
usa
determin
differ
control
test
group
use
oneway
anova
student
ttest
surviv
rate
percentag
tumorfre
mice
evalu
use
logrank
mantelcox
test
valu
p
consid
statist
signific
